| scholarly article | Q13442814 |
| meta-analysis | Q815382 |
| P356 | DOI | 10.1111/CEN.13480 |
| P698 | PubMed publication ID | 28940393 |
| P50 | author | Yanan Cao | Q58069431 |
| Lei Ye | Q87883136 | ||
| P2093 | author name string | Wei Zhu | |
| Lei Jiang | |||
| Shu Wang | |||
| Guang Ning | |||
| Yulin Zhou | |||
| Jieli Lu | |||
| Weiqing Wang | |||
| Weixi Wang | |||
| William F Young | |||
| Nancy D Perrier | |||
| Naykky Singh Ospina | |||
| Ioannis Christakis | |||
| P2860 | cites work | Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement | Q27860537 |
| Prognostic significance of overexpressed p16INK4a in patients with cervical cancer: a meta-analysis | Q34133777 | ||
| Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). | Q34283436 | ||
| Causes of death and prognostic factors in multiple endocrine neoplasia type 1: a prospective study: comparison of 106 MEN1/Zollinger-Ellison syndrome patients with 1613 literature MEN1 patients with or without pancreatic endocrine tumors | Q37056120 | ||
| Clinical Features, Treatments, and Outcomes of Patients with Thymic Carcinoids and Multiple Endocrine Neoplasia Type 1 Syndrome at MD Anderson Cancer Center | Q38867386 | ||
| Thymic neuroendocrine tumors in multiple endocrine neoplasia type 1: a comparative study on 21 cases among a series of 761 MEN1 from the GTE (Groupe des Tumeurs Endocrines). | Q39994289 | ||
| Thymic and Bronchial Carcinoid Tumors in Multiple Endocrine Neoplasia Type 1: The Mayo Clinic Experience from 1977 to 2013. | Q41674195 | ||
| Thymic neuroendocrine tumour in multiple endocrine neoplasia type 1: female patients are not rare exceptions | Q43972215 | ||
| Risk factors and causes of death in MEN1 disease. A GTE (Groupe d'Etude des Tumeurs Endocrines) cohort study among 758 patients | Q44301609 | ||
| Outcome of primary neuroendocrine tumors of the thymus: a joint analysis of the International Thymic Malignancy Interest Group and the European Society of Thoracic Surgeons databases | Q44558782 | ||
| When and how should patients with multiple endocrine neoplasia type 1 be screened for thymic and bronchial carcinoid tumours? | Q47913061 | ||
| Natural course and survival of neuroendocrine tumors of thymus and lung in MEN1 patients. | Q50671382 | ||
| Prospective study of thymic carcinoids in patients with multiple endocrine neoplasia type 1. | Q53657069 | ||
| P433 | issue | 6 | |
| P921 | main subject | multiple endocrine neoplasia | Q1553018 |
| multiple endocrine neoplasia type 1 | Q3347154 | ||
| P304 | page(s) | 706-716 | |
| P577 | publication date | 2017-10-16 | |
| P1433 | published in | Clinical Endocrinology | Q15762781 |
| P1476 | title | Clinical features and prognosis of thymic neuroendocrine tumours associated with multiple endocrine neoplasia type 1: A single-centre study, systematic review and meta-analysis | |
| P478 | volume | 87 |
| Q64230407 | Adrenocortical carcinoma in patients with MEN1: a kindred report and review of the literature |
| Q58569013 | Capecitabine and Temozolomide as a Promising Therapy for Advanced Thymic Atypical Carcinoid |
| Q90003324 | p.L105Vfs mutation in a family with thymic neuroendocrine tumor combined with MEN1: a case report |
Search more.